Overview
What is Melanoma Research Foundation Breakthrough Consortium Inc?
Melanoma Research Foundation Breakthrough Consortium Inc is a nonprofit organization headquartered in Washington D.C., specifically at 1420 K Street NW 7th Floor. Their primary mission is to accelerate research and development of promising therapeutics for melanoma, aiming to deliver curative options to patients. To achieve this, they establish collaborative, multi-sector partnerships across various melanoma disciplines, including basic, translational, and clinical science. They support clinical trials, drug development, and research related to melanoma treatment and prevention. The consortium also creates a virtual annotated specimen biorepository and identifies biomarkers with predictive and prognostic value or potential as new therapeutic targets. They conduct outreach to various partners in the melanoma research field to stay updated on developments and promising research.
Official website here: www.melanoma.org/research/mrf-breakthrough-consor
What do the Facebook reviews say about Melanoma Research Foundation Breakthrough Consortium Inc?
92% of 342 reviewers on Facebook recommend the Melanoma Research Foundation Breakthrough Consortium Inc. Here’s an overview of their thoughts:
The organization is highly regarded for its commitment to supporting individuals affected by melanoma, with many users expressing gratitude for the resources and information provided. Reviewers appreciate the foundation's focus on raising awareness about melanoma and facilitating research that could lead to better treatment options. Some testimonials convey a sense of community, where individuals feel encouraged and supported in their struggles with the disease.
While many praises focus on the foundation's mission and impact, some users also share personal experiences highlighting the challenges in accessing treatment options. Specifically, one reviewer discussed the financial burden associated with necessary medications not available in their country, emphasizing the need for greater support and options for patients. Overall, the sentiment leans positively, portraying the nonprofit as a vital ally for melanoma patients and their families.
This AI summary has been generated from reviews found on Facebook.
Is Melanoma Research Foundation Breakthrough Consortium Inc legitimate?
Melanoma Research Foundation Breakthrough Consortium Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Melanoma Research Foundation Breakthrough Consortium Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.melanoma.org/research/mrf-breakthrough-consor
What is the mission statement of Melanoma Research Foundation Breakthrough Consortium Inc?
The Melanoma Research Foundation Breakthrough Consortium Inc's mission is to expedite the development of promising therapeutics for melanoma, aiming to provide curative options for patients. They achieve this by fostering collaborative, cross-disciplinary partnerships in basic, translational, and clinical science. The consortium supports pre-clinical research to facilitate rational combinations, develops a virtual annotated biorepository, and identifies biomarkers with prognostic and predictive value or potential as new therapeutic targets. The ultimate goal is to accelerate research and development in melanoma treatment and prevention.
Official website here: www.melanoma.org/research/mrf-breakthrough-consor
What is the revenue of Melanoma Research Foundation Breakthrough Consortium Inc?
Melanoma Research Foundation Breakthrough Consortium Inc's revenue in 2021 was $320,000.
Official website here: www.melanoma.org/research/mrf-breakthrough-consor
Who are the executives of Melanoma Research Foundation Breakthrough Consortium Inc and what are their salaries?
There 7 volunteers at Melanoma Research Foundation Breakthrough Consortium Inc.
Here are 7 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.melanoma.org/research/mrf-breakthrough-consor
Where can I find the form 990 for Melanoma Research Foundation Breakthrough Consortium Inc?
Melanoma Research Foundation Breakthrough Consortium Inc's most recent form 990 was submitted in 2021 and can be accessed here.
Official website here: www.melanoma.org/research/mrf-breakthrough-consor
Learn more at the official website: www.melanoma.org/research/mrf-breakthrough-consor
Mission Statement of Melanoma Research Foundation Breakthrough Consortium Inc
The Melanoma Research Foundation Breakthrough Consortium Inc is committed to accelerating the research and development of promising therapeutics in melanoma. Their mission is to establish collaborative partnerships across various disciplines of melanoma research, including basic, translational, and clinical science. This collaboration aims to expedite the development of combinations of therapies as well as novel single agents.
To achieve this, the Consortium supports pre-clinical research to facilitate rationally designed combinations. Additionally, they are creating a virtual annotated specimen biorepository, which will serve as a valuable resource for researchers. Furthermore, the Consortium is identifying biomarkers that have prognostic and predictive value or can be used as new therapeutic targets. By pursuing these objectives, the Melanoma Research Foundation Breakthrough Consortium Inc aims to deliver curative options to patients battling melanoma.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
October, 2024
The Melanoma Research Foundation Breakthrough Consortium Inc significantly impacts the field of melanoma research and treatment by accelerating the development of promising therapeutics aimed at providing curative options for patients. By fostering collaborative, multi-sector partnerships across various disciplines—basic, translational, and clinical science—the Consortium enhances the efficiency and effectiveness of research efforts.
Key initiatives include supporting clinical trials, drug development, and preclinical research, which are essential for identifying and validating rational combinations of therapies. The creation of a virtual annotated specimen biorepository enables researchers to access vital resources, while the identification of biomarkers with prognostic, predictive, or novel therapeutic value is pivotal for driving targeted treatment strategies.
In addition, the Consortium actively engages outreach to various partners invested in melanoma research, ensuring that it remains informed about the latest developments and promising advancements in the field. This comprehensive approach not only bolsters the scientific understanding of melanoma but also translates into real-world applications that can significantly improve patient outcomes. Through these efforts, the Consortium addresses critical gaps in melanoma treatment and prevention, ultimately working toward a future where curative options are accessible to all patients affected by this aggressive form of skin cancer.
This information is meant to be a general summary of Melanoma Research Foundation Breakthrough Consortium Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2021.
- Gross Receipts: $320,000
Assets and Liabilities:
- Total Assets: $0
- Total Liabilities: $0
- Net Assets: $0
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2010
Principal Officer
Anthony T Hendrickson
NTEE Category
Code: H30 - Medical research
If you are a representative of Melanoma Research Foundation Breakthrough Consortium Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.